File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Edge-to-edge percutaneous repair of severe mitral regurgitation - state-of-the-art for Mitraclip® implantation -

TitleEdge-to-edge percutaneous repair of severe mitral regurgitation - state-of-the-art for Mitraclip® implantation -
Authors
Issue Date2012
Citation
Circulation Journal, 2012, v. 76 n. 4, p. 801-808 How to Cite?
AbstractMitraClip® therapy is a percutaneous edge-to-edge plication of the mitral leaflets, mimicking the Alfieri surgical technique. MitraClip® implantation is a safe procedure, and survival outcomes in high-surgical-risk patients are superior to historical controls. Despite these results, questions remain concerning long-term efficacy and durability. The MitraClip® device has been studied in a safety and feasibility trial in the USA, a randomized pivotal trial against surgical mitral valve repair. Moreover, MitraClip® now has over 2 years of CE-mark approval and a rapidly expanding clinical experience in Europe, primarily in patients at high risk for surgery. A dedicated multidisciplinary team is necessary, as well as thoughtful patient selection, familiarity with the technical aspects of the procedure, including transesophageal ultrasound imaging and post-procedure monitoring. Currently available clinical data and procedural steps are herein reviewed. Because the MitraClip® procedure is still relatively new, continued investigation is required to further better define the patient populations that will benefit most.
Persistent Identifierhttp://hdl.handle.net/10722/194354
ISSN
2015 Impact Factor: 4.124
2015 SCImago Journal Rankings: 1.728
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorAlegria-Barrero, E-
dc.contributor.authorChan, PH-
dc.contributor.authorPaulo, M-
dc.contributor.authorDuncan, A-
dc.contributor.authorPrice, S-
dc.contributor.authorMoat, N-
dc.contributor.authordi Mario, C-
dc.contributor.authorSerra, A-
dc.contributor.authorGarcía, E-
dc.contributor.authorFranzen, O-
dc.date.accessioned2014-01-30T03:32:29Z-
dc.date.available2014-01-30T03:32:29Z-
dc.date.issued2012-
dc.identifier.citationCirculation Journal, 2012, v. 76 n. 4, p. 801-808-
dc.identifier.issn1346-9843-
dc.identifier.urihttp://hdl.handle.net/10722/194354-
dc.description.abstractMitraClip® therapy is a percutaneous edge-to-edge plication of the mitral leaflets, mimicking the Alfieri surgical technique. MitraClip® implantation is a safe procedure, and survival outcomes in high-surgical-risk patients are superior to historical controls. Despite these results, questions remain concerning long-term efficacy and durability. The MitraClip® device has been studied in a safety and feasibility trial in the USA, a randomized pivotal trial against surgical mitral valve repair. Moreover, MitraClip® now has over 2 years of CE-mark approval and a rapidly expanding clinical experience in Europe, primarily in patients at high risk for surgery. A dedicated multidisciplinary team is necessary, as well as thoughtful patient selection, familiarity with the technical aspects of the procedure, including transesophageal ultrasound imaging and post-procedure monitoring. Currently available clinical data and procedural steps are herein reviewed. Because the MitraClip® procedure is still relatively new, continued investigation is required to further better define the patient populations that will benefit most.-
dc.languageeng-
dc.relation.ispartofCirculation Journal-
dc.titleEdge-to-edge percutaneous repair of severe mitral regurgitation - state-of-the-art for Mitraclip® implantation --
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1253/circj.CJ-11-1462-
dc.identifier.pmid22374149-
dc.identifier.scopuseid_2-s2.0-84858955655-
dc.identifier.volume76-
dc.identifier.issue4-
dc.identifier.spage801-
dc.identifier.epage808-
dc.identifier.isiWOS:000301996700006-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats